AT-21 FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM)

BACKGROUND: PVSRIPO is the live attenuated, oral (SABIN) serotype 1 poliovirus vaccine containing a heterologous internal ribosomal entry site stemming from human rhinovirus type 2. PVSRIPO recognizes nectin-like molecule-5, an oncofetal cell adhesion molecule and tumor antigen widely expressed ecto...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Desjardins, Annick, Sampson, John, Peters, Katherine, Vlahovic, Gordana, Threatt, Stevie, Herndon, James, Boulton, Susan, Lally-Goss, Denise, McSherry, Frances, Lipp, Eric, Friedman, Allan, Friedman, Henry, Bigner, Darell, Gromeier, Matthias
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217799/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.21
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars